In pediatric myopia management, I've found that parents respond best when we translate abstract refractive errors into something they can visualise. The most effective education tool we've used is a simple progression chart that plots a child's current prescription against the expected trajectory with and without treatment. During the consultation I pull up a graph that looks like a growth chart: one line shows how quickly the child's myopia could progress without intervention, and a second line shows the flattened curve when using orthokeratology lenses or low-dose atropine drops. When parents see that untreated myopia could progress from -2.00 D to -6.00 D by high school, while treatment could keep it near -3.00 D, the benefit becomes tangible. Along with the chart, I use a short script that frames myopia control like dental braces. I explain that just as braces gently guide teeth into alignment, ortho-k lenses gently reshape the front of the eye overnight to slow elongation, and atropine drops relax the focusing mechanism to reduce the stimulus for growth. This analogy helps parents understand that we're not curing myopia overnight but guiding growth over years. A phrase that resonates with many parents is: "It's much easier to slow a rolling snowball than to stop an avalanche. Starting early prevents bigger problems later." For at-home adherence, a one-page handout with "top three tips" has been more effective than lengthy instructions. Ours reminds parents and kids to wash hands before handling lenses or drops, stick to the prescribed schedule (e.g., one drop per night at the same time, or lenses in at bedtime and out upon waking), and schedule regular follow-ups. We also include an icon-based checklist for kids to mark off each night, which encourages their involvement and gives parents a quick way to monitor compliance. Families who used the chart reported fewer missed doses and fewer comfort issues because they were more mindful about insertion hygiene. Overall, combining a visual progression chart, a relatable analogy and a concise adherence handout helps parents appreciate why myopia management is worth the investment and keeps them engaged throughout the treatment plan. (This answer is general educational information and not a substitute for professional medical advice.)
Founder & Medical Director at New York Cosmetic Skin & Laser Surgery Center
Answered 4 months ago
I am a dermatologist in Manhattan, so parents ask me everything. The visual that drives enrollment is a one-page axial-length bar chart. Placebo next to low-dose atropine. In the 2025 ORANGE randomized trial, axial length grew 0.74 mm at 24 months on placebo versus 0.64 mm with 0.01% and 0.51 mm with 0.025%. I point, pause, then say, "We are slowing the eye from stretching longer." For at-home adherence, I keep it blunt. "Same two minutes nightly, no debate." The handout is a fridge checklist built on a habit: brush, drop or lens care, check the box, sleep. Families like streaks more than lectures. A 2025 adherence review notes myopia-control studies often rely on indirect, self-reported adherence, so tracking matters.
In myopia management consults, the most effective education tool is a simple eye growth chart showing future risk, not fear. One short phrase that works is growth control protects future choices. Parents respond to clarity. A one page take home guide with nightly routine steps improved adherence. Visual simplicity matters. When parents understand the why and the how, enrollment and follow through both increase.